These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16638740)

  • 1. Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers.
    Hesse LM; Greenblatt DJ; von Moltke LL; Court MH
    J Clin Pharmacol; 2006 May; 46(5):567-76. PubMed ID: 16638740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related reduction in bupropion plasma concentrations by ritonavir.
    Park J; Vousden M; Brittain C; McConn DJ; Iavarone L; Ascher J; Sutherland SM; Muir KT
    J Clin Pharmacol; 2010 Oct; 50(10):1180-7. PubMed ID: 20484617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects.
    Hogeland GW; Swindells S; McNabb JC; Kashuba AD; Yee GC; Lindley CM
    Clin Pharmacol Ther; 2007 Jan; 81(1):69-75. PubMed ID: 17186001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
    Jefferson JW; Pradko JF; Muir KT
    Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a high-throughput stereoselective LC-MS/MS assay for bupropion, hydroxybupropion, erythrohydrobupropion, and threohydrobupropion in human plasma.
    Teitelbaum AM; Flaker AM; Kharasch ED
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1017-1018():101-113. PubMed ID: 26963497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers.
    Lei HP; Yu XY; Xie HT; Li HH; Fan L; Dai LL; Chen Y; Zhou HH
    Xenobiotica; 2010 Apr; 40(4):275-81. PubMed ID: 20102294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of cimetidine on the pharmacokinetics of sustained-release bupropion.
    Kustra R; Corrigan B; Dunn J; Duncan B; Hsyu PH
    J Clin Pharmacol; 1999 Nov; 39(11):1184-8. PubMed ID: 10579150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.
    Kim H; Bae SK; Park SJ; Shim EJ; Kim HS; Shon JH; Liu KH; Shin JG
    Br J Clin Pharmacol; 2010 Jul; 70(1):126-31. PubMed ID: 20642555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4'-OH-bupropion in vitro.
    Sager JE; Price LS; Isoherranen N
    Drug Metab Dispos; 2016 Oct; 44(10):1709-19. PubMed ID: 27495292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.
    Reese MJ; Wurm RM; Muir KT; Generaux GT; St John-Williams L; McConn DJ
    Drug Metab Dispos; 2008 Jul; 36(7):1198-201. PubMed ID: 18420781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, validation and application of a comprehensive stereoselective LC/MS-MS assay for bupropion and oxidative, reductive, and glucuronide metabolites in human urine.
    Teitelbaum AM; Flaker AM; Kharasch ED
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():239-53. PubMed ID: 27318149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir.
    Gutierrez MM; Rosenberg J; Abramowitz W
    Clin Ther; 2003 Apr; 25(4):1200-10. PubMed ID: 12809966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chirality and neuropsychiatric drugs: an update on stereoselective disposition and clinical pharmacokinetics of bupropion.
    Dash RP; Rais R; Srinivas NR
    Xenobiotica; 2018 Sep; 48(9):945-957. PubMed ID: 28876959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion.
    Laib AK; Brünen S; Pfeifer P; Vincent P; Hiemke C
    Ther Drug Monit; 2014 Aug; 36(4):473-9. PubMed ID: 24452068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study.
    Daviss WB; Perel JM; Brent DA; Axelson DA; Rudolph GR; Gilchrist R; Nuss S; Birmaher B
    Ther Drug Monit; 2006 Apr; 28(2):190-8. PubMed ID: 16628130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers.
    Hsyu PH; Singh A; Giargiari TD; Dunn JA; Ascher JA; Johnston JA
    J Clin Pharmacol; 1997 Aug; 37(8):737-43. PubMed ID: 9378846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender.
    Stewart JJ; Berkel HJ; Parish RC; Simar MR; Syed A; Bocchini JA; Wilson JT; Manno JE
    J Clin Pharmacol; 2001 Jul; 41(7):770-8. PubMed ID: 11452710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of bupropion and its main metabolite in rat plasma by LC-MS and its application to pharmacokinetics.
    Hu L; Wang Z; Xu R; Ma J; Wang X; Zhang X
    Pharmazie; 2011 Dec; 66(12):924-8. PubMed ID: 22312695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a Potential Pharmacokinetic Interaction between Nebivolol and Bupropion in Healthy Volunteers.
    Gheldiu AM; Popa A; Neag M; Muntean D; Bocsan C; Buzoianu A; Vlase L; Tomuta I; Briciu C
    Pharmacology; 2016; 98(3-4):190-8. PubMed ID: 27300331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state pharmacokinetics of bupropion SR in juvenile patients.
    Daviss WB; Perel JM; Rudolph GR; Axelson DA; Gilchrist R; Nuss S; Birmaher B; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2005 Apr; 44(4):349-57. PubMed ID: 15782082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.